AKT1 and liver cancer: However, following UGCG inhibition, no alterations in phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) and RAF)/mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase signaling were detected in liver cancer cells [30].